Surrogate endpoints in trials: a call for better reporting

被引：3
|
作者：
Ciani, Oriana [1 ]
Manyara, Anthony M. [2 ]
Chan, An-Wen [3 ,4 ]
Taylor, Rod S. [2 ,5 ]
机构：
[1] SDA Bocconi Sch Management, Milan, Italy
[2] Univ Glasgow, Inst Hlth & Wellbeing, MRC CSO Social & Publ Hlth Sci Unit, Berkeley Sq,99 Berkeley St, Glasgow G3 7HR, Lanark, Scotland
[3] Univ Toronto, Womens Coll Inst Res Inst, Toronto, ON, Canada
[4] Univ Toronto, Dept Med, Toronto, ON, Canada
[5] Univ Glasgow, Inst Hlth & Wellbeing, Robertson Ctr Biostat, Berkeley Sq,99 Berkeley St, Glasgow G3 7HR, Lanark, Scotland
来源：
TRIALS | 2022年 / 23卷 / 01期
基金：
英国医学研究理事会;
关键词：
Surrogate endpoints; Randomised trials;
D O I：
10.1186/s13063-022-06904-7
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Using a surrogate endpoint as a substitute for a patient-relevant final outcome enables randomised controlled trials (RCTs) to be conducted more efficiently. However, the use of surrogates remains controversial and there is currently no guideline for the reporting of RCTs using surrogate endpoints; therefore, we seek to develop SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) and CONSORT (Consolidated Standards of Reporting Trials) extensions to improve the reporting of these trials. We would like to invite interested individuals (trial methodologists, journal editors, healthcare industry, regulators and payers, and patient/public representative groups), particularly those with experience in the use of surrogate endpoints in trials.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Surrogate endpoints in trials: a call for better reporting
    Oriana Ciani
    Anthony M. Manyara
    An-Wen Chan
    Rod S. Taylor
    Trials, 23
  • [2] Surrogate endpoints in trials-a call for better reporting
    Ciani, Oriana
    Manyara, Anthony M.
    Taylor, Rod S.
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 378
  • [3] A call for better reporting of trials using surrogate primary endpoints
    Manyara, Anthony Muchai
    Ciani, Oriana
    Taylor, Rod S.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)
  • [4] Commentary on: A call for better reporting of trials using surrogate primary endpoints
    Cummings, Jeffrey
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)
  • [5] Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
    Ciani, Oriana
    Manyara, Anthony
    Taylor, Rod S.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2022, 76 (09) : 769 - 770
  • [6] Surrogate endpoints in randomised trials of physiotherapy interventions: the SPIRIT and CONSORT extension checklists for better reporting
    Faria, Christina D. C. M.
    Polese, Janaine Cunha
    Manyara, Anthony Muchai
    Taylor, Rod S.
    Ciani, Oriana
    Scianni, Aline Alvim
    JOURNAL OF PHYSIOTHERAPY, 2025, 71 (01) : 1 - 3
  • [7] Transparent and complete reporting of surrogate endpoints in trials: the SPIRIT-Surrogate and CONSORT-Surrogate extensions
    Manyara, Anthony Muchai
    Ciani, Oriana
    Taylor, Rod S.
    LANCET, 2024, 404 (10450): : 322 - 324
  • [8] Clinical trials: Surrogate endpoints or hard endpoints?
    Kuller, LH
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (2A): : 59E - 61E
  • [9] Surrogate end points in cardio-thoracic trials: a call for better reporting and improved interpretation of trial findings
    Ciani, Oriana
    Manyara, Anthony Muchai
    Taylor, Rod S.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 62 (04)
  • [10] Surrogate endpoints in early trials
    Buyse, M
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 35 - 35
12345